-TheWire.in A Tata Nano pays the same toll to go from Mumbai and Pune on the expressway as does a Rolls Royce. Why should pharmaceutical products be any different? On May 26, amid news reports about yet another closed-door meeting that the National Pharmaceutical Pricing Authority (NPPA) had had with unspecified stakeholders, we were reminded of an interesting press release that the Ministry of Chemicals and Fertilisers had issued in July 2021. The...
More »SEARCH RESULT
Total Matching Records found : 45
The tightrope walk of India's drug-price regulator -Anuj Gupta
-The Economic Times The genesis: The National Pharmaceutical Pricing Authority (NPPA) was set up to implement the 1995 Drug Price Control Order (DPCO) and monitor overcharging of drugs and medical devices When: August 29, 1997 Total number of chairmen: 11 What the chairman has to deliver: * Implement and enforce the provisions of the DPCO * Render advice to the central government on drug pricing Highlights of the chairmen's tenures * Between 2001 and 2004, five chairmen were...
More »Why NPPA didn't wait for govt to make knee implants 'essential' -Rema Nagarajan
-The Times of India In a first for a medical device, the public interest provision in the Drug Price Control Order (DPCO) 2013 was used by the National Pharmaceutical Pricing Authority to cap the price of knee implants. The NPPA cited "exorbitant prices being charged from patients in a non-regulated market" and "a failed market system where asymmetry of information between patient and the doctor has resulted into unethical practices and...
More »Govt forms panel to make drugs more affordable
-PTI The government has formed a committee in its bid to make drugs more affordable in the country, Parliament was informed on Tuesday. “Government has constituted a committee of joint secretaries for ensuring enhanced affordability, availability and accessibility of drugs for the citizens,” Minister of State for Chemicals and Fertilisers Mansukh L. Mandaviya said in a written reply to Lok Sabha. Elaborating on the terms of reference of the committee, the minister said...
More »Centre cracks whip, no stent can be withdrawn, for now -Sushmi Dey
-The Times of India NEW DELHI: The government has invoked special powers under the law to prohibit stent makers from withdrawing their products from the market for the next six months. Amid reports that several manufacturers, including Abbott and Medtronic, are seeking to withdraw premium, high-priced stents from the Indian market on account of the price cap imposed by National Pharmaceutical Pricing Authority (NPPA), the government has directed companies to maintain production,...
More »
